Kaplan-Meier survival analysis of PTPN12 expression in patients with HCC (log-rank test).

<p><b>A.</b> The PTPN12 expression and the probability of cancer-specific survival of all patients with HCC: decreased expression, n = 147, normal expression, n = 101. <b>B.</b> Probability of cancer-specific survival of the PTPN12 expression in HCC patients at stage I-II: l decreased expression, n = 99, normal expression, n = 74. <b>C.</b> Probability of cancer-specific survival of the PTPN12 expression in HCC patients at stage III-IV: decreased expression, n = 48, normal expression, n = 27. <b>D.</b> The PTPN12 expression and the probability of recurrence-free survival of all patients with HCC: decreased expression, n = 147, normal expression, n = 101. <b>E.</b> Probability of recurrence-free survival of the PTPN12 expression in HCC patients at stage I-II: l decreased expression, n = 99, normal expression, n = 74. <b>F.</b> Probability of recurrence-free survival of the PTPN12 expression in HCC patients at stage III-IV: decreased expression, n = 48, normal expression, n = 27.